Correlation Between 4D Molecular and Cue Biopharma
Can any of the company-specific risk be diversified away by investing in both 4D Molecular and Cue Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining 4D Molecular and Cue Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between 4D Molecular Therapeutics and Cue Biopharma, you can compare the effects of market volatilities on 4D Molecular and Cue Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in 4D Molecular with a short position of Cue Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of 4D Molecular and Cue Biopharma.
Diversification Opportunities for 4D Molecular and Cue Biopharma
-0.78 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between FDMT and Cue is -0.78. Overlapping area represents the amount of risk that can be diversified away by holding 4D Molecular Therapeutics and Cue Biopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cue Biopharma and 4D Molecular is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on 4D Molecular Therapeutics are associated (or correlated) with Cue Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cue Biopharma has no effect on the direction of 4D Molecular i.e., 4D Molecular and Cue Biopharma go up and down completely randomly.
Pair Corralation between 4D Molecular and Cue Biopharma
Given the investment horizon of 90 days 4D Molecular Therapeutics is expected to under-perform the Cue Biopharma. But the stock apears to be less risky and, when comparing its historical volatility, 4D Molecular Therapeutics is 2.87 times less risky than Cue Biopharma. The stock trades about -0.21 of its potential returns per unit of risk. The Cue Biopharma is currently generating about 0.13 of returns per unit of risk over similar time horizon. If you would invest 66.00 in Cue Biopharma on September 2, 2024 and sell it today you would earn a total of 56.00 from holding Cue Biopharma or generate 84.85% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
4D Molecular Therapeutics vs. Cue Biopharma
Performance |
| Timeline |
| 4D Molecular Therapeutics |
| Cue Biopharma |
4D Molecular and Cue Biopharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with 4D Molecular and Cue Biopharma
The main advantage of trading using opposite 4D Molecular and Cue Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if 4D Molecular position performs unexpectedly, Cue Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cue Biopharma will offset losses from the drop in Cue Biopharma's long position.| 4D Molecular vs. Revolution Medicines | 4D Molecular vs. Black Diamond Therapeutics | 4D Molecular vs. Passage Bio | 4D Molecular vs. Century Therapeutics |
| Cue Biopharma vs. Coya Therapeutics, Common | Cue Biopharma vs. Lantern Pharma | Cue Biopharma vs. Fennec Pharmaceuticals | Cue Biopharma vs. Eliem Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Other Complementary Tools
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences |